Consolidated Guidelines

Care and support interventions for all people with TB (Guideline update 2017)

1. In patients with TB, are any interventions to promote adherence to TB treatment more or less likely to lead to the outcomes listed below?

This section contains two new recommendations on the implementation of decentralized models of care and integrated family-centred models of care to improve both case detection and the provision of TB preventive treatment (TPT).

Annex 1.1. Experts participating in the guideline update, 2017

Guideline Development Group (GDG) members

Si Thu Aung, Deputy Director (TB) and National TB Programme Manager, Ministry of Health, Nay Pyi Taw, Myanmar (Unable to attend the meeting)

Frank Bonsu, National TB Programme Manager, Ministry of Health, Accra, Ghana

Jeremiah Muhwa Chakaya, Clinician, National TB Programme Manager, Nairobi, Kenya

Lucy Chesire, Nairobi, Kenya

1. Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 update. Geneva: World Health Organization; 2011.
2. Guidelines for treatment of drug-susceptible tuberculosis and patient care – 2017 update. Geneva: World Health Organization; 2017.
3. WHO consolidated guidelines on tuberculosis. Module 5: Co-morbidities, vulnerable populations and people-centred care. Management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022.

The Global TB Programme (GTB) of the World Health Organization (WHO) has been combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations regarding all areas related to the programmatic management of TB (e.g. screening, preventive treatment, diagnostics, the treatment of drug-susceptible and drug-resistant TB, patient care and support). The consolidated guidelines contain modules specific to each programmatic area.

The recommendations and remarks contained in this document were formulated by three different Guideline Development Groups (GDGs) convened by the Global TB Programme (GTB) of the World Health Organization (WHO) in Geneva, Switzerland. The original documents were: Guideline update on management of drug-resistant TB, 2011; Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update; and WHO consolidated guidelines on tuberculosis.